These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 336315)

  • 21. [HLA typing in high risk keratoplasty].
    Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
    Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differential effect of incompatibilities of the HLA-A and HLA-B locus on the success of corneal transplants].
    Baumgartner I; Mayr WR; Hajek-Rosenmayr A; Grabner G
    Klin Monbl Augenheilkd; 1988 Jul; 193(1):48-51. PubMed ID: 3054252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Initial experience with HLA typing in high-risk keratoplasty].
    Halás M; Oláh Z; Bencová M
    Cesk Oftalmol; 1992 Mar; 48(2):92-5. PubMed ID: 1525885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
    Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
    Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of corneal transplantation and human leukocyte antigen matching].
    Liu Y; Zhang R; Guan L
    Zhonghua Yan Ke Za Zhi; 1996 Sep; 32(5):369-71. PubMed ID: 9590831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-B 12 and HLA-B 27 antigens and susceptibility to the corneal allograft reaction.
    Vannas S; Tiilikainen A; Vannas A; Karjalainen K
    Acta Ophthalmol (Copenh); 1978 Oct; 56(5):689-96. PubMed ID: 358729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunobiology of corneal transplantation.
    Williams KA; Coster DJ
    Transplantation; 2007 Oct; 84(7):806-13. PubMed ID: 17984831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HLA typing and corneal grafts].
    Duchesne B
    Bull Soc Belge Ophtalmol; 1993; 247(1):29-32. PubMed ID: 8205333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Typing for HLA matching. Advantages for keratoplasty].
    Ignatius R; Hoffmann F
    Ophthalmologe; 2007 Mar; 104(3):213-8. PubMed ID: 17353999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved renal allograft survival with selected HLA antigen matching.
    Gifford RR; Schmidtke JR; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1979 Aug; 86(2):316-22. PubMed ID: 380037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current clinician's opinions on risk factors in corneal grafting. Results of a survey among surgeons in the eurotransplant area.
    Beekhuis WH
    Cornea; 1995 Jan; 14(1):39-42. PubMed ID: 7712735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
    Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HLA matching in keratoplasty: lessons learned from lamellar techniques].
    Böhringer D; Schwartzkopff J; Maier PC; Reinhard T
    Klin Monbl Augenheilkd; 2013 May; 230(5):490-3. PubMed ID: 23695845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of HLA-A, HLA-B, and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing.
    Bartels MC; Otten HG; van Gelderen BE; Van der Lelij A
    Br J Ophthalmol; 2001 Nov; 85(11):1341-6. PubMed ID: 11673303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of HLA-DR matching on the survival of corneal allografts.
    Völker-Dieben HJ; Claas FH; Schreuder GM; Schipper RF; Pels E; Persijn GG; Smits J; D'Amaro J
    Transplantation; 2000 Aug; 70(4):640-8. PubMed ID: 10972223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between HLA-DPB1 matching and 1-year rejection-free graft survival in high-risk corneal transplantation.
    Munkhbat B; Hagihara M; Sato T; Tsuchida F; Sato K; Shimazaki J; Tsubota K; Tsuji K
    Transplantation; 1997 Apr; 63(7):1011-6. PubMed ID: 9112356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superiority of B locus matching over other HLA matching in renal graft survival.
    Dewar PJ; Wilkinson R; Elliott RW; Ward MK; Kerr DN; Kenward DH; Proud G; Taylor RM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):779-82. PubMed ID: 6802225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Corneal transplantation--immunological mechanisms of rejection episode].
    Cwalina L; Mrukwa-Kominek E
    Klin Oczna; 2004; 106(4-5):686-90. PubMed ID: 15646495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.